Atlas Trials

Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

Clinical trial NCT07059767 · RECRUITING

Trial details

NCT number
NCT07059767
Sponsor
Ethris GmbH
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma (Diagnosis)
Start date
2025-06-24
Primary completion
2026-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.